HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$34.45
+0.29 (+0.85%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-9.65%
1Y
+7.45%
YTD
-7.84%
Open$34.50
Previous Close$34.16
Day High$35.12
Day Low$34.33
52W High$40.87
52W Low$25.52
Volume—
Avg Volume827.0K
Market Cap1.93B
P/E Ratio13.23
EPS$2.49
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.42
Below
SMA 200
$34.21
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+171.5% upside
Current
$34.45
$34.45
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 829.37M | 660.12M | 502.35M |
| Net Income | 151.54M | 108.56M | 88.37M |
| Profit Margin | 18.3% | 17.4% | 17.6% |
| EBITDA | 221.86M | 167.76M | 150.20M |
| Free Cash Flow | — | — | 92.06M |
| Rev Growth | +25.6% | +25.6% | +14.6% |
| Debt/Equity | 0.19 | 0.19 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |